Ribonucleicacid interference or small molecule inhibition of<i>Runx</i>1 in the border zone prevents cardiac contractile dysfunction following myocardial infarction

Abstract

Our results confirm the translational potential of RUNX1 as a novel therapeutic target in MI, with wider opportunities for use across a range of cardiac diseases where RUNX1 drives adverse cardiac remodelling.